News Headline Summary

AstraZeneca (AZN LN) says no boost from baseline in mean daily Opioid dose

- Co. announces results from long-term safety trial of Naloxegol in patients with Opioid induced constipation.

Reaction details:

- Co. shares unreactive, trades down 0.97% at GBP 29.49 last.

Print 11:32, 26 Feb 2013 - FTSE 100 - Source: Newswires